Approvals (Drugs@FDA)

NADOLOL

INGENUS PHARMS LLC · NADOLOL

ANDA210786Generic (ANDA)Discontinued
Open FDA's page for this record
Application number
ANDA210786
Sponsor name
INGENUS PHARMS LLC
Submissions
  1. Submission type
    SUPPL
    Submission number
    1
    Submission status
    AP
    Submission status date
    20240531
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
  2. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20180601
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
Products
  1. Product number
    003
    Reference drug
    No
    Brand name
    NADOLOL
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Discontinued
    Active ingredients
    1. Name
      NADOLOL
      Strength
      80MG
  2. Product number
    001
    Reference drug
    No
    Brand name
    NADOLOL
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Discontinued
    Active ingredients
    1. Name
      NADOLOL
      Strength
      20MG
  3. Product number
    002
    Reference drug
    No
    Brand name
    NADOLOL
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Discontinued
    Active ingredients
    1. Name
      NADOLOL
      Strength
      40MG
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.